PAK4 and cancer: Selective elevation of PAK4 protein, with no changes in other PAK members, and AMPKα2 phosphorylation at S491 were consistently observed in various muscle atrophy models, including those induced by cancer cachexia, hindlimb suspension, and aging (Figure 1B; Figure S1B–D).